Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Gu SJ, Guo ZR, Zhou ZY, Hu XS, Wu M.

Lipids Health Dis. 2014 Jan 26;13:23. doi: 10.1186/1476-511X-13-23.

2.

Gene-gene interactions among PPARα/δ/γ polymorphisms for hypertriglyceridemia in Chinese Han population.

Gu SJ, Liu MM, Guo ZR, Wu M, Chen Q, Zhou ZY, Zhang LJ, Luo WS.

Gene. 2013 Feb 25;515(2):272-6. doi: 10.1016/j.gene.2012.11.078. Epub 2012 Dec 20.

PMID:
23262340
3.

Peroxisome proliferator‑activated receptor γ polymorphisms as risk factors for dyslipidemia.

Gu SJ, Guo ZR, Zhou ZY, Hu XS, Wu M, Zhang N.

Mol Med Rep. 2014 Nov;10(5):2759-63. doi: 10.3892/mmr.2014.2553. Epub 2014 Sep 10.

PMID:
25216344
4.

[Association and interaction of peroxisome proliferator-activated receptor α with low high-density lipoprotein hyperlipidemia and with peroxisome proliferator-activated receptor γ].

Liu MM, Gu SJ, Guo ZR, Wu M, Chen Q, Zhou ZY, Yu H, Ding Y, Luo WS.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Dec;33(12):1218-23. Chinese.

PMID:
23336188
5.

PPARα polymorphisms as risk factors for dyslipidemia in a Brazilian population.

Mazzotti DR, Singulane CC, Ota VK, Rodrigues TP, Furuya TK, de Souza FJ, Cordeiro BG, Magalhães C, Chen ES, Jacomini A, Smith Mde A, Borsatto-Galera B.

Mol Genet Metab. 2011 Feb;102(2):189-93. doi: 10.1016/j.ymgme.2010.11.156. Epub 2010 Dec 15.

PMID:
21159535
6.

Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: a case-control study of a Chinese Han population.

Shi H, Yu X, Li Q, Ye X, Gao Y, Ma J, Cheng J, Lu Y, Du W, Du J, Ye Q, Zhao X, Zhou L.

Arch Med Res. 2012 Apr;43(3):233-42. doi: 10.1016/j.arcmed.2012.03.006. Epub 2012 Apr 2.

PMID:
22475777
7.

[Association between polymorphisms, haplotypes of peroxisome proliferators activated receptor a gene and the level of lipoprotein (a)].

Xie H, Hai B, Guo Z, Zhou Z, Liu M, Wu M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Jul;35(7):787-91. Chinese.

PMID:
25294067
8.

[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension].

Liu A, Li L, Cao W, Shan S, Lu J, Guo X, Hu Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Apr;22(2):151-7. Chinese.

PMID:
15793775
9.

[Association and interaction between 10 SNP of peroxisome proliferator-activated receptor and non-HDL-C].

Liu M, Zhang J, Guo Z, Wu M, Chen Q, Zhou Z, Ding Y, Luo W.

Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Mar;49(3):259-64. Chinese.

PMID:
26268872
10.

Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan.

Chu NF, Lin FH, Chin HC, Hong YJ.

Lipids Health Dis. 2011 Aug 12;10:136. doi: 10.1186/1476-511X-10-136.

11.

[Association of both peroxisome proliferator-activated receptor, gene-gene interactions and the body mass index].

Luo WS, Guo ZR, Wu M, Chen Q, Zhou ZY, Yu H, Zhang LJ, Liu JC.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jul;33(7):740-5. Chinese.

PMID:
22968028
12.

Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han population.

Fan W, Shen C, Wu M, Zhou ZY, Guo ZR.

Genet Test Mol Biomarkers. 2015 Jul;19(7):379-86. doi: 10.1089/gtmb.2015.0002. Epub 2015 Jun 22.

13.

Association between APOE, SCARB1, PPARα polymorphisms and serum lipids in a population of Lithuanian adults.

Smalinskiene A, Petkeviciene J, Luksiene D, Jureniene K, Klumbiene J, Lesauskaite V.

Lipids Health Dis. 2013 Aug 6;12:120. doi: 10.1186/1476-511X-12-120.

14.

[Genotype and haplotype analysis of peroxisome proliferators activated receptor α gene and the risk of essential hypertension].

Ding Y, Guo ZR, Wu M, Zhou ZY, Chen Q, Yu H, Luo WS.

Zhonghua Yi Xue Za Zhi. 2012 Sep 11;92(34):2398-401. Chinese.

PMID:
23158661
15.

Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.

Luo W, Guo Z, Wu M, Hao C, Hu X, Zhou Z, Zhou Z, Yao X, Zhang L, Liu J.

J Epidemiol. 2013;23(3):187-94. Epub 2013 Apr 1.

16.

[Gene-gene interactions among the peroxisome proliferator-activated receptor polymorphisms for hypertriglyceridemia].

Gu SJ, Liu MM, Guo ZR, Wu M, Chen Q, Zhou ZY, Yu H, Zhang LJ, Luo WS.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Oct;46(10):916-21. Chinese.

PMID:
23363867
17.

Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.

Penyige A, Poliska S, Csanky E, Scholtz B, Dezso B, Schmelczer I, Kilty I, Takacs L, Nagy L.

BMC Med Genet. 2010 Nov 2;11:152. doi: 10.1186/1471-2350-11-152.

18.

[Association between peroxisome proliferator-activated receptor and gene-gene interactions with the apolipoprotein A I/apolipoprotein B100 ratio].

Hai B, Ni C, Xie H, Guo Z, Wu M, Chen Q, Zhou Z, Fan W, Zhou H.

Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Apr;43(4):328-33. Chinese.

PMID:
26082365
19.

Gene- gene interaction between CYP2J2 and PPAR -γ gene on late-onset Alzheimer's disease in the eastern Chinese Han population.

Geng S, Wang Y, Sun Y, Li J, Yin H, Zeng Z, Yang X, Zhang Y, Wang Y.

Behav Brain Res. 2017 Mar 30;322(Pt B):362-367. doi: 10.1016/j.bbr.2016.07.010. Epub 2016 Jul 7.

PMID:
27396818
20.

Association of NCOA2 gene polymorphisms with obesity and dyslipidemia in the Chinese Han population.

Lu Y, Habtetsion TG, Li Y, Zhang H, Qiao Y, Yu M, Tang Y, Zhen Q, Cheng Y, Liu Y.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7341-9. eCollection 2015.

Supplemental Content

Support Center